Thor Medical ASA (FRA:8NN) Dividend Yield %: 0.00% (As of Jun. 26, 2026)


FRA:8NN Thor Medical ASA FRA:8NN
21 GF Score
Price €0.38
! 2 Warning Signs
View Full Analysis

What is Thor Medical ASA Dividend Yield %?

Thor Medical ASA FRA:8NN +2.42% 21 Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates FRA:8NN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 151 Biotechnology companies, Thor Medical ASA ranks worse than 662250.99% on this metric.

As of today (2026-06-26), the Trailing Annual Dividend Yield of Thor Medical ASA is 0.00%.

The historical rank and industry rank for Thor Medical ASA's Dividend Yield % or its related term are showing as below:

FRA:8NN's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.53
* Ranked among companies with meaningful Dividend Yield % only.

Thor Medical ASA's Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00.

As of today (2026-06-26), the Forward Dividend Yield % of Thor Medical ASA is 0.00%.

Thor Medical ASA's Dividends per Share for the six months ended in Dec. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Thor Medical ASA  (FRA:8NN) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Thor Medical ASA Dividend Yield % Related Terms


Thor Medical ASA Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA Dividend Yield % Chart

Thor Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Thor Medical ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:8NN vs VRTX, REGN, ALNY: Dividend Yield % Comparison

For the Biotechnology subindustry, Thor Medical ASA's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thor Medical ASA Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Dividend Yield % falls into.


FRA:8NN
21GF Score
Thor Medical ASA FRA:8NN
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Thor Medical ASA (FRA:8NN) has a Dividend Yield % of 0.00% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Thor Medical ASA and its competitors. According to the industry distribution chart, Thor Medical ASA ranks #999999 out of 151 companies in the Biotechnology industry.
Is Thor Medical ASA's Dividend Yield % too high?
Thor Medical ASA's current Dividend Yield % is 0.00%. Based on the distribution chart, Thor Medical ASA ranks #999999 out of 151 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Thor Medical ASA has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Thor Medical ASA's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Thor Medical ASA ranks #999999 out of 151 companies for Dividend Yield %. This places Thor Medical ASA in the lower half of its industry. The industry median Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.53, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Thor Medical ASA and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thor Medical ASA's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thor Medical ASA stock overvalued right now?
Thor Medical ASA (FRA:8NN) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Thor Medical ASA's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Thor Medical ASA (FRA:8NN), the current Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway0R6Y:UK
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
21GF Score

Get the complete analysis for FRA:8NN

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.38
Price